Figure 2.
(A) Physical stability of the nanoparticles. (B) In vitro release of nanoparticles and liraglutide solution (first 2 h in simulated gastric fluid; 2–24 h in simulated intestinal fluid).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.